Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD

Eric Hollander, Lisa J. Cohen, Concetta DeCaria, Jihad B. Saoud, Dan J. Stein, Thomas B. Cooper, Nazrul N. Islam, Michael R. Liebowitz, Donald F. Klein

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The present study assesses the timing of and relationship between neuroendocrine response and metabolite blood levels following the partial serotonin (5-HT) agonist m-CPP and the 5-HT releaser/reuptake blocker fenfluramine. Cortisol levels peaked significantly earlier than did prolactin, m-CPP, fenfluramine, or norfenfluramine blood levels by time-to-peak analysis. This earlier cortisol response to both 5-HT agents raises the possibility that peripheral mechanisms may play a role cortisol release. Since peak m-CPP level correlated even more closely to peak prolactin rise than did peak fenfluramine, this suggests that prolactin response to oral m-CPP challenge is useful in assessing 5-HT function.

Original languageEnglish (US)
Pages (from-to)407-413
Number of pages7
JournalBiological Psychiatry
Volume34
Issue number6
DOIs
StatePublished - Sep 15 1993
Externally publishedYes

Fingerprint

Fenfluramine
Serotonin
Prolactin
Hydrocortisone
Norfenfluramine
Serotonin Receptor Agonists
1-(3-chlorophenyl)piperazine

Keywords

  • cortisol
  • fenfluramine
  • M-CPP
  • obsessive-compulsive disorder
  • prolactin
  • serotonin

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Hollander, E., Cohen, L. J., DeCaria, C., Saoud, J. B., Stein, D. J., Cooper, T. B., ... Klein, D. F. (1993). Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD. Biological Psychiatry, 34(6), 407-413. https://doi.org/10.1016/0006-3223(93)90186-H

Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD. / Hollander, Eric; Cohen, Lisa J.; DeCaria, Concetta; Saoud, Jihad B.; Stein, Dan J.; Cooper, Thomas B.; Islam, Nazrul N.; Liebowitz, Michael R.; Klein, Donald F.

In: Biological Psychiatry, Vol. 34, No. 6, 15.09.1993, p. 407-413.

Research output: Contribution to journalArticle

Hollander, E, Cohen, LJ, DeCaria, C, Saoud, JB, Stein, DJ, Cooper, TB, Islam, NN, Liebowitz, MR & Klein, DF 1993, 'Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD', Biological Psychiatry, vol. 34, no. 6, pp. 407-413. https://doi.org/10.1016/0006-3223(93)90186-H
Hollander, Eric ; Cohen, Lisa J. ; DeCaria, Concetta ; Saoud, Jihad B. ; Stein, Dan J. ; Cooper, Thomas B. ; Islam, Nazrul N. ; Liebowitz, Michael R. ; Klein, Donald F. / Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD. In: Biological Psychiatry. 1993 ; Vol. 34, No. 6. pp. 407-413.
@article{9772e97e8e0d45faad05c2970242ea39,
title = "Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD",
abstract = "The present study assesses the timing of and relationship between neuroendocrine response and metabolite blood levels following the partial serotonin (5-HT) agonist m-CPP and the 5-HT releaser/reuptake blocker fenfluramine. Cortisol levels peaked significantly earlier than did prolactin, m-CPP, fenfluramine, or norfenfluramine blood levels by time-to-peak analysis. This earlier cortisol response to both 5-HT agents raises the possibility that peripheral mechanisms may play a role cortisol release. Since peak m-CPP level correlated even more closely to peak prolactin rise than did peak fenfluramine, this suggests that prolactin response to oral m-CPP challenge is useful in assessing 5-HT function.",
keywords = "cortisol, fenfluramine, M-CPP, obsessive-compulsive disorder, prolactin, serotonin",
author = "Eric Hollander and Cohen, {Lisa J.} and Concetta DeCaria and Saoud, {Jihad B.} and Stein, {Dan J.} and Cooper, {Thomas B.} and Islam, {Nazrul N.} and Liebowitz, {Michael R.} and Klein, {Donald F.}",
year = "1993",
month = "9",
day = "15",
doi = "10.1016/0006-3223(93)90186-H",
language = "English (US)",
volume = "34",
pages = "407--413",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD

AU - Hollander, Eric

AU - Cohen, Lisa J.

AU - DeCaria, Concetta

AU - Saoud, Jihad B.

AU - Stein, Dan J.

AU - Cooper, Thomas B.

AU - Islam, Nazrul N.

AU - Liebowitz, Michael R.

AU - Klein, Donald F.

PY - 1993/9/15

Y1 - 1993/9/15

N2 - The present study assesses the timing of and relationship between neuroendocrine response and metabolite blood levels following the partial serotonin (5-HT) agonist m-CPP and the 5-HT releaser/reuptake blocker fenfluramine. Cortisol levels peaked significantly earlier than did prolactin, m-CPP, fenfluramine, or norfenfluramine blood levels by time-to-peak analysis. This earlier cortisol response to both 5-HT agents raises the possibility that peripheral mechanisms may play a role cortisol release. Since peak m-CPP level correlated even more closely to peak prolactin rise than did peak fenfluramine, this suggests that prolactin response to oral m-CPP challenge is useful in assessing 5-HT function.

AB - The present study assesses the timing of and relationship between neuroendocrine response and metabolite blood levels following the partial serotonin (5-HT) agonist m-CPP and the 5-HT releaser/reuptake blocker fenfluramine. Cortisol levels peaked significantly earlier than did prolactin, m-CPP, fenfluramine, or norfenfluramine blood levels by time-to-peak analysis. This earlier cortisol response to both 5-HT agents raises the possibility that peripheral mechanisms may play a role cortisol release. Since peak m-CPP level correlated even more closely to peak prolactin rise than did peak fenfluramine, this suggests that prolactin response to oral m-CPP challenge is useful in assessing 5-HT function.

KW - cortisol

KW - fenfluramine

KW - M-CPP

KW - obsessive-compulsive disorder

KW - prolactin

KW - serotonin

UR - http://www.scopus.com/inward/record.url?scp=0027420971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027420971&partnerID=8YFLogxK

U2 - 10.1016/0006-3223(93)90186-H

DO - 10.1016/0006-3223(93)90186-H

M3 - Article

VL - 34

SP - 407

EP - 413

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 6

ER -